Lower urinary tract dysfunction in children in neuropsychiatric practice
https://doi.org/10.21518/ms2025-258
Abstract
Lower urinary tract dysfunction in children is a complex set of disorders affecting not only physiological, but also neuropsychiatric aspects of development. Understanding the pathophysiological mechanisms underlying overactive bladder and other forms of lower urinary tract dysfunction allows for a more effective approach to the diagnosis and treatment of these conditions. It is important to remember that the delay in the development of the nervous regulation of urination, the peculiarities of brain functioning and concomitant psychological factors play a key role in the onset and maintenance of symptoms of lower urinary tract dysfunction. The key point in the successful management of children with urinary dysfunction is an integrated approach that takes into account all factors affecting the function of the bladder and intestines, as well as the psycho-emotional state of the child. Careful history collection, detailed examination and adequate interpretation of the results make it possible to avoid erroneous diagnoses and prescribe effective treatment. Timely detection and medical correction of not only urological, but also neuropsychiatric problems in children with urinary dysfunction is the key to improving the child’s quality of life and preventing the development of long-term psychological and social consequences. Underestimation of psychoemotional factors can significantly reduce the effectiveness of treatment and lead to the chronization of the process. Further research in this area is needed to develop more effective and personalized approaches to the treatment of urinary dysfunction in children, taking into account both physiological and psychosocial aspects.
About the Authors
O. V. Bykova
Research and Clinical Center of Pediatric Psychoneurology; Peoples’ Friendship University of Russia named after Patrice Lumumba
Russian Federation
Russian Federation
Olga V. Bykova - Dr. Sci. (Med.), Pediatric Neurologist, Head of the Research Department, Research and Clinical Center of Pediatric Psychoneurology; Professor of the Department of Neurology, Physical and Rehabilitation Medicine of Children, Peoples’ Friendship University of Russia named after Patrice Lumumba.
74, Michurinsky Ave., Moscow, 119602; 6, Miklukho-Maklai St., Moscow, 117198
I. Ya. Bogdan
Research and Clinical Center of Pediatric Psychoneurology
Russian Federation
Russian Federation
Igor Ya. Bogdan - Cand. Sci. (Med.), Leading Researcher, Scientific Research and Practical Center of Pediatric Psychoneurology.
74, Michurinsky Ave., Moscow, 119602
M. V. Alekseeva
Research and Clinical Center of Pediatric Psychoneurology; Peoples’ Friendship University of Russia named after Patrice Lumumba
Russian Federation
Russian Federation
Marina V. Alekseeva - Cand. Sci. (Med.), Deputy Director for Organizational and Methodological Work, Research and Clinical Center of Pediatric Psychoneurology; Assistant Professor of the Department of Neurology, Physical and Rehabilitation Medicine for Children, Peoples’ Friendship University of Russia named after Patrice Lumumba.
74, Michurinsky Ave., Moscow, 119602; 6, Miklukho-Maklai St., Moscow, 117198
References
1. Belousova IS, Sukhorukov VS. The use of metabolic drugs in treating children with hyperactive urinary bladder. Current Pediatrics. 2005;4(6):22–27. (In Russ.) Available at: https://www.elibrary.ru/pclnwl.
2. Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr. 2006;18(2):139–147. https://doi.org/10.1097/01.mop.0000193289.64151.49.
3. Tekgul S, Stein R, Bogaert G, Undre S, Nijman RJM, Quaedackers J et al. EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children. Eur J Pediatr. 2020;179(7):1069–1077. https://doi.org/10.1007/s00431-020-03681-w.
4. Franco I. Overactive bladder in children. Nat Rev Urol. 2016;13(9):520–532. https://doi.org/10.1038/nrurol.2016.152.
5. Franco I. Overactive bladder in children. Part 1: Pathophysiology. J Urol. 2007;178(3):761–768. https://doi.org/10.1016/j.juro.2007.05.014.
6. Franco I. Pediatric overactive bladder syndrome: pathophysiology and management. Paediatr Drugs. 2007;9(6):379–390. https://doi.org/10.2165/00148581-200709060-00005.
7. Ramsay S, Bolduc S. Overactive bladder in children. Can Urol Assoc J. 2017;11(1):S74–S79. https://doi.org/10.5489/cuaj.4337.
8. Vishnevskiy E. Оveractive bladder syndrome in children. Current Pediatrics. 2007;6(2):63–70. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/1025.
9. Santos JD, Lopes RI, Koyle MA. Bladder and bowel dysfunction in children: an update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem. Can Urol Assoc J. 2017;11(1):S64– S72. https://doi.org/10.5489/cuaj.4411.
10. Shim J, Oh MM. Updates of Overactive Bladder in Pediatrics. Int Neurourol J. 2023;27(1):3–14. https://doi.org/10.5213/inj.2244228.114.
11. Bael A, Lax H, de Jong TP, Hoebeke P, Nijman RJ, Sixt R et al. The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children. J Urol. 2008;180(4):1486–1493. https://doi.org/10.1016/j.juro.2008.06.054.
12. Hall JE, Hall ME. Guyton and hall textbook of medical physiology. 14th ed. Philadelphia (PA): Elsevier Health Sciences; 2021. 1152 p.
13. Iguchi N, Malykhina AP, Wilcox DT. Early life voiding dysfunction leads to lower urinary tract dysfunction through alteration of muscarinic and purinergic signaling in the bladder. Am J Physiol Renal Physiol. 2018;315(5):F1320– F1328. https://doi.org/10.1152/ajprenal.00154.2018.
14. Yamaguchi O, Chapple CR. Beta3-adrenoceptors in urinary bladder. Neurourol Urodyn. 2007;26(6):752–756. https://doi.org/10.1002/nau.20420.
15. Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn. 2010;29(1):49–55. https://doi.org/10.1002/nau.20740.
16. Drake MJ, Fowler CJ, Griffiths D, Mayer E, Paton JF, Birder L. Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn. 2010;29(1):119–127. https://doi.org/10.1002/nau.20841.
17. Chung JM, Lee SD, Kang DI, Kwon DD, Kim KS, Kim SY et al. Prevalence and associated factors of overactive bladder in Korean children 5–13 years old: a nationwide multicenter study. Urology. 2009;73(1):63–67. https://doi.org/10.1016/j.urology.2008.06.063.
18. Milsom I, Coyne KS, Nicholson S, Kvasz M, Chen CI, Wein AJ. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2014;65(1):79–95. https://doi.org/10.1016/j.eururo.2013.08.031.
19. Griffiths D, Tadic SD. Bladder control, urgency, and urge incontinence: evidence from functional brain imaging. Neurourol Urodyn. 2008;27(6):466–74. https://doi.org/10.1002/nau.20549.
20. Michel MC, Chapple CR. Basic mechanisms of urgency: preclinical and clinical evidence. Eur Urol. 2009;56(2):298–307. https://doi.org/10.1016/j.eururo.2009.05.028.
21. Beckel JM, Holstege G. Neurophysiology of the lower urinary tract. Handb Exp Pharmacol. 2011;(202):149–169. https://doi.org/10.1007/978-3-642-16499-6_8.
22. Franco I, Cagliostro S, Collet-Gardere T. Treatment of lower urinary tract symptoms in children with constipation using tegaserod therapy. Urotoday Int J. 2010;3(3). https://doi.org/10.3834/uij.1944-5784.2010.06.17.
23. Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology. 2010;138(5):1783–1789. https://doi.org/10.1053/j.gastro.2009.12.043.
24. Griffiths D, Derbyshire S, Stenger A, Resnick N. Brain control of normal and overactive bladder. J Urol. 2005;174(5):1862–1867. https://doi.org/10.1097/01.ju.0000177450.34451.97.
25. Joinson C, Heron J, von Gontard A. Psychological problems in children with daytime wetting. Pediatrics. 2006;118(5):1985–1993. https://doi.org/10.1542/peds.2006-0894.
26. Equit M, Klein AM, Braun-Bither K, Gräber S, von Gontard A. Elimination disorders and anxious-depressed symptoms in preschool children: a population-based study. Eur Child Adolesc Psychiatry. 2014;23(6):417–423. https://doi.org/10.1007/s00787-013-0468-9.
27. Niemczyk J, Equit M, Braun-Bither K, Klein AM, von Gontard A. Prevalence of incontinence, attention deficit/hyperactivity disorder and oppositional defiant disorder in preschool children. Eur Child Adolesc Psychiatry. 2015;24(7):837–843. https://doi.org/10.1007/s00787-014-0628-6.
28. Joinson C, Heron J, Emond A, Butler R. Psychological problems in children with bedwetting and combined (day and night) wetting: A UK population-based study. J Pediatr Psychol. 2007;32(5):605–616. https://doi.org/10.1093/jpepsy/jsl039.
29. Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O et al. Child and adolescent mental health worldwide: evidence for action. Lancet. 2011;378(9801):1515–1525. https://doi.org/10.1016/S0140-6736(11)60827-1.
30. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015;56(3):345–365. https://doi.org/10.1111/jcpp.12381.
31. von Gontard A, Baeyens D, Van Hoecke E, Warzak WJ, Bachmann C. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185(4):1432–1436. https://doi.org/10.1016/j.juro.2010.11.051.
32. Dourado ER, de Abreu GE, Santana JC, Macedo RR, da Silva CM, Rapozo PMB et al. Emotional and behavioral problems in children and adolescents with lower urinary tract dysfunction: a population-based study. J Pediatr Urol. 2019;15(4):376.e1–376.e7. https://doi.org/10.1016/j.jpurol.2018.12.003.
33. Farhat W, Bägli DJ, Capolicchio G, O’Reilly S, Merguerian PA, Khoury A, McLorie GA. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol. 2000;164(3): 1011–1015. https://doi.org/10.1097/00005392-200009020-00023.
34. Rahmanipur A, Sarmadian R, Salehi B, Yousefichaijan P, Habibi D. Comparison of child abuse history in patients with and without overactive bladder: a case-control study. Ann Med Surg. 2023;85(7):3264–3268. https://doi.org/10.1097/MS9.0000000000000859.
35. Hägglöf B, Andrén O, Bergström E, Marklund L, Wendelius M. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol. 1998;33(3):16–19. https://doi.org/10.1159/000052236.
36. Keane L, Loades M. Review: Low self-esteem and internalizing disorders in young people – a systematic review. Child Adolesc Ment Health. 2017;22(1):4–15. https://doi.org/10.1111/camh.12204.
37. Gao Y, Rodríguez LV. The Effect of Chronic Psychological Stress on Lower Urinary Tract Function: An Animal Model Perspective. Front Physiol. 2022;13:818993. https://doi.org/10.3389/fphys.2022.818993.
38. Khan MA, Novikova EV, Popova OF. The medical rehabilitation of the children presenting with the hyperactive urinary bladder. Problems of Balneology, Physiotherapy and Therapeutic Physical Culture. 2015;92(6):56–58. (In Russ.) https://doi.org/10.17116/kurort2015656-58.
39. Nevéus T, Fonseca E, Franco I, Kawauchi A, Kovacevic L, Nieuwhof-Leppink A et al. Management and treatment of nocturnal enuresis-an updated standardization document from the International Children’s Continence Society. J Pediatr Urol. 2020;16(1):10–19. https://doi.org/10.1016/j.jpurol.2019.12.020.
40. Chancellor MB, Lucioni A, Staskin D. Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment. Urology. 2024;186:123–129. https://doi.org/10.1016/j.urology.2023.11.033.
41. Iyen B, Coupland C, Bell BG, Ashcroft DM, Orrell MW, Bishara D et al. Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years: nested case-control study. BMJ Med. 2024;3(1):e000799. https://doi.org/10.1136/bmjmed-2023-000799.
42. Kim YJ, Tae BS, Bae JH. Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms. Int Neurourol J. 2020;24(3):231–240. https://doi.org/10.5213/inj.2040082.041.
43. Баранов АА, Батышева ТТ, Буркина АГ, Быкова ОВ, Вишнева ЕА, Врублевская ЕН и др. Энурез: клинические рекомендации. 2024. Режим доступа: https://diseases.medelement.com/disease/энурез-кп-рф-2024/18379.
44. Zorkin SN, Maslova OI, Artyukhina SV, Borisova SA. The effect of neuro-transmitter amino acid derivatives on urodynamic parameters of children with neurogenic bladder dysfunction. Lechaschi Vrach. 2011;(1):61–63. (In Russ.) Available at: https://www.lvrach.ru/2011/01/15435106.
45. Трошкин ВМ, Радаева ТМ, Куркина СА. Расстройства мочеиспускания у детей. 1998. 24 с. Режим доступа: http://www.neuronet.ru/bibliot/b001/enures2.html.
46. Марушкин ДВ, Петров ВИ, Папаян АВ. Результаты применения пикамилона в терапии недержания мочи у детей. В: Пикамилон в лечебной практике: материалы российской конференции. М.; 1994. Режим доступа: https://web.archive.org/web/20050216204434/http://medi.ru/doc/12057107.htm
Review
For citations:
Bykova OV, Bogdan IY, Alekseeva MV. Lower urinary tract dysfunction in children in neuropsychiatric practice. Meditsinskiy sovet = Medical Council. 2025;(11):212-218. (In Russ.) https://doi.org/10.21518/ms2025-258
Views:
23
Email this article 